Johnson & Johnson has settled another case this year, and this time for its case in Australia concerning the pelvic mesh class action lawsuit. It was reported that the healthcare and pharmaceutical company headquartered in New Brunswick, New Jersey reached a $204.9 million or AUS$300 million agreement to settle two suits.
The settlement has been described as the biggest in the country's history but is still subject to federal court approval. The class action suits were filed by Shine Lawyers on behalf of the Australian women.
The Brisbane-based law firm that specializes in personal injury compensation law filed two lawsuits against Johnson & Johnson. The lawyers said on Monday, Sept. 12 that it sued the company for the sale of defective pelvic mesh implants to Australian women.
The Shine Lawyers affirmed that this is the largest settlement in a product-liability class action in the entire history of Australia. The settlement was reached after a number of court proceedings with over 11,000 claimants. Johnson & Johnson's subsidiary, Ethicon Inc., was also involved in the lawsuit, as per Reuters.
The settlement earlier this week also revealed that the Australian federal court judge previously found Ethicon to have sold the mesh implants used for treating urinary incontinence and pelvic organ prolapse. The court said the company sold the device without warning surgeons and women about the risks.
The judge further said Ethicon rushed the products and released them to the market before proper testing could be done. In response to the settlement, Johnson & Johnson's spokesman said, "Pending the Federal Court approval, we are pleased to reach a settlement that provides certainty and a path forward for eligible Australian patients."
The Guardian reported that women who had implants using the mesh suffered complications such as cuts through internal tissue, fistula formation, vaginal scarring, painful sex, and pains in the back, pelvic and leg areas. Some of these complications may be difficult to treat and could occur years after surgery. Finally, Rebecca Jancauskas of Shine Lawyers said the Johnson & Johnson settlement would be very helpful to women who are undergoing treatments for complications.
"We welcome this settlement which brings the litigation to an end," the lawyer said "If the federal court approves the settlement our focus will shift to the important task of distributing the settlement to group members."


MAS Holds Monetary Policy Steady as Strong Growth Raises Inflation Risks
Meta Stock Surges After Q4 2025 Earnings Beat and Strong Q1 2026 Revenue Outlook Despite Higher Capex
UK Politicians Call for Full Competition Review of Netflix’s Warner Bros Discovery Deal
Philippine Economy Slows in Late 2025, Raising Expectations of Further Rate Cuts
ECB’s Cipollone Backs Digital Euro as Europe Pushes for Payment System Independence
Dollar Slumps to Four-Year Lows as Trump Shrugs Off Weakness, Fueling Confidence Crisis
RBA Expected to Raise Interest Rates by 25 Basis Points in February, ANZ Forecast Says
ASML’s EUV Lithography Machines Power Europe’s Most Valuable Tech Company
Asian Stock Markets Rise on AI Optimism Ahead of Fed Decision and U.S. Tech Earnings
China Approves First Import Batch of Nvidia H200 AI Chips Amid Strategic Shift
China to Boost Brazilian Soybean Imports in Early 2026 Amid Price Advantage
UK Vehicle Production Falls Sharply in 2025 Amid Cyberattack, Tariffs, and Industry Restructuring
Bank of Canada Holds Interest Rate at 2.25% Amid Trade and Global Uncertainty
Asian Currencies Slip as Dollar Rebounds Ahead of Fed Rate Decision
UK Housing Market Gains Momentum in Early 2026 as Mortgage Rates Fall
SoftBank Shares Surge as It Eyes Up to $30 Billion New Investment in OpenAI
Meta Faces Lawsuit Over Alleged Approval of AI Chatbots Allowing Sexual Interactions With Minors 



